WASHINGTON, CT, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Evexia Diagnostics, a leading provider of ...

A salivary miRNA test for endometriosis shows high accuracy; however, experts debate whether it can replace laparoscopy.

Researchers found that an NHS test for ovarian cancer in premenopausal women performs poorly, with ultrasound‑based methods demonstrating increased accuracy.

The finger-prick blood test employs a plasma separation card, designed to cut costs and simplify testing procedures.

Guardant and MSD will evaluate opportunities to develop new oncology therapies using liquid biopsy tests.

Probius to develop AI-powered point-of-care screening technology, eliminating sample preparation requirements and ...

En Carta Diagnostics receives FDA Breakthrough Device Designation for EC Pocket Lyme test Breakthrough device status for rapid, Point-of-Need molecular diagnostic platform will fill critical gap in ...

Lucid's Q3 2025 showed 2,841 tests and $7.1 million in pro forma revenues billed, but only $1.2 million could be ...

Fungal testing in outpatient community-acquired pneumonia was uncommon, and few tested patients were diagnosed with ...

Strong Buy reiterated with a €8.37 target price following the 21 January 2026 Flash; last close on 22 January 2026: ...